The present study revealed the potential role of Bin1 methylation in ESCC carcinogenesis, suggesting that the DAC-based restoration of Bin1 could be a potential therapeutic strategy for improving the prognosis of ESCC patients. This evidence concerns the gene BIN1 and esophageal squamous cell carcinoma.